Trial Profile
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2020
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Acute myeloid leukaemia; Aplastic anaemia; Lymphoma; Mycoses; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- 14 Feb 2020 Status changed from active, no longer recruiting to completed.
- 06 Jul 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 06 Jul 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.